Filing Details
- Accession Number:
- 0001645113-23-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-09 18:18:44
- Reporting Period:
- 2023-01-05
- Accepted Time:
- 2023-01-09 18:18:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654435 | Asaf Danziger | C/O Novocure Inc. 1550 Liberty Ridge Drive, Suite 115 Wayne PA 19087 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-01-05 | 25,000 | $11.46 | 38,583 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 8,369 | $111.23 | 30,214 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 2,000 | $112.86 | 28,214 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 4,568 | $114.35 | 23,646 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 3,702 | $115.21 | 19,944 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 1,395 | $116.06 | 18,549 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 999 | $117.01 | 17,550 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 2,123 | $118.47 | 15,427 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 1,344 | $119.35 | 14,083 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 500 | $119.99 | 13,583 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-01-05 | 187,500 | $7.15 | 201,083 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-01-05 | 187,500 | $108.00 | 13,583 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-01-06 | 39 | $62.31 | 13,622 | No | 5 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 5 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2023-01-05 | 25,000 | $0.00 | 25,000 | $11.46 |
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2023-01-05 | 187,500 | $0.00 | 187,500 | $7.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-24 | No | 4 | M | Direct | |
| 0 | 2027-02-22 | No | 4 | M | Direct |
Footnotes
- Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Danziger.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 8,369 shares in multiple trades at prices ranging from $111.00 to $111.97. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 2,000 shares in multiple trades at prices ranging from $112.29 to $113.26. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 4,568 shares in multiple trades at prices ranging from $113.76 to $114.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 3,702 shares in multiple trades at prices ranging from $114.79 to $115.78. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,395 shares in multiple trades at prices ranging from $115.79 to $116.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 999 shares in multiple trades at prices ranging from $116.85 to $117.82. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 2,123 shares in multiple trades at prices ranging from $117.91 to $118.90. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,344 shares in multiple trades at prices ranging from $118.95 to $119.84. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 500 shares in multiple trades at prices ranging from $119.98 to $120.00. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- In accordance with the issuer's Employee Share Purchase Plan, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022.
- Fully vested as of the date hereof.
Billionaire Hedge Funds
